Trademark Overview
On Monday, January 19, 2026, a trademark application was filed for OLYMAVUS with the United States Patent and Trademark Office. The USPTO has given the OLYMAVUS trademark a serial number of 79444400. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 26, 2026. This trademark is owned by CELLTRION, INC.. The OLYMAVUS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for human use; antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of inflammatory diseases.